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Biofilms are microbial derived sessile communities characterized by cells that are irreversibly 
attached to a substratum, or to each other, and embedded in a matrix of extracellular polymeric 
substances that they have produced [1]. Such micro-organisms exhibit an altered phenotype with 
respect to growth rate and gene transcription [2]. Biofilms forming on implanted medical devices 
are problematic as the extra cellular matrix exported by the micro-organisms along with the 
changes in their physiology result in the requirement to remove the device to effect a cure [3, 4]. 
Pseudomonas aeruginosa (P. aeruginosa) is a human opportunistic pathogen that colonizes 
biotic and abiotic surfaces and has emerged as a primary source of nosocomial infections [5], 
especially in cystic fibrosis sufferers and immuno-compromised patients [6]. The bacterium 
almost never infects uncompromised tissues, yet there is hardly any tissue that it cannot infect if 
the tissue defences are compromised in some manner, such as in severe burns sufferers [7]. In the 
United States, P. aeruginosa ranked first among all nosocomial pathogens related to pneumonia 
in intensive care units reported to the National Nosocomial Infection Surveillance System [8]. 
Pseudomonas sp. in general and P. aeruginosa, specifically, has resistance to antibiotics 
including aminoglycosides and quinolones, and this is steadily increasing [9]. The mechanisms 
of biofilm formation are poorly understood and effective prevention and therapeutic strategies 
still need to be developed for device-associated infections. Treatment with antibiotics can slow 
down biofilm progression by eliminating planktonic cells and interfering with biofilm 
metabolism [10], but complete removal is rare. Other eradication methods that have been 
employed include prevention of initial attachment of bacterial cells by constructing materials into 
which antimicrobial agents have been incorporated [10] and minimizing biofilm formation by the 
disruption of quorum-signalling molecules, allowing for improved inactivation and removal [11]. 
Glass polyalkenoate cements (GPCs), formed by the reaction between an ion-leachable glass and 
an aqueous solution of polyacrylic acid (PAA) [12], are both antibacterial and cariostatic [13]; 
properties related to their ability to release beneficial amounts of therapeutic ions [14, 15].  
Studies have shown that inhibition of bacterial growth correlates with zinc (Zn
2+
) and silver 
(Ag
+
) ion release from novel GPCs [16, 17]. Zn
2+
 has been shown to inhibit multiple activities in 
the bacterial cell including glycolysis, transmembrane protein translocation and acid tolerance 
[18]. It also influences pH, which rises throughout glycolysis via the action of Zn
2+
 on the 
bacterial cell wall and therefore leaves an excess of OH
-
 that results in a favourable bioactive 
response [19]. The minimum Zn
2+
 concentration required for P. aeruginosa inhibition is 
 3 
6.02×10
-4 
µg/ml [20] and 8µg/ml for biofilm inhibition [21]. Ag
+
 is also a known antibacterial 
agent [22, 23]. To have antimicrobial efficacy against P. aeruginosa bacteria, Ag
+
 must be 
released in biocidal concentrations of 1.102×10
-6 
µg/ml [24] and 5 µg/ml for biofilm inhibition 
[25]. Ag
+
 avidly binds to negatively charged components in proteins and nucleic acids, thereby 
causing structural changes in bacterial cell walls, membranes and nucleic acids that affect 
viability [26].  
It is accepted that novel Zn-Ag-GPCs are antibacterial against a clinical isolate of P. aeruginosa 
[16], but the objective of the work reported herein is to determine whether such a material can 
inhibit the proliferation of a biofilm forming from P. aeruginosa. 
A glass (56.04SiO2, 32.76ZnO, 0.33Ag2O, Na2O10.87 mol%) was synthesized by mixing 
appropriate amounts of analytical grade reagents in a ball mill (1 h), then firing the mixture in a 
mullite crucible (1480°C, 1 h), prior to shock quenching into water. The resulting frit was ground 
down and all further work was undertaken on sub 25 μm particles. The GPC was prepared by 
mixing 0.5 g glass with 0.2 g PAA (Mw, 210,000, Ciba Specialty Polymers, Bradford, UK) and 
0.25 ml distilled water on a clean glass plate with a dental spatula in ambient laboratory 
conditions. Cement constructs (Figure 1) were produced by placing the cement into moulds (4 
mmØ, 6 mm ht) and maturing in an oven (37˚C, 24 h). Ion release from the GPC was already 
reported [16], but is included here (Figure 2) for completeness. In agreement with the literature 
[27], the majority of Zn
2+
 (1.5 ppm) and Ag
+
 (0.2 ppm) release occurred in the first 24 hours.  
 
 
Figure 1: Samples of GPC alongside the mould. 
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Figure 2: Cumulative ion release profiles for Zinc and Silver from the GPC. 
 
The bacterial strain used in this study was P. aeruginosa (PAO1), a clinical wound isolate [28], 
obtained from the Iglewiski laboratory (University of Rochester, NY, USA). Bacterial cultures 
were grown overnight in Lysogeny Broth (LB broth, Difco, Oxford, UK) supplemented with 
0.5% of a 1M Glucose (Glu) solution (Sigma Aldrich, Dublin, Ireland) added in a Sanyo MIR-
162 Incubator (San Diego, USA) at 30˚C. The turbidity of the culture was then measured (@ 
595nm) using a spectrophotometer (6300 Series Spectroscopy, Jenway, Staffs, UK). The culture 
was then diluted using fresh LB/Glu Broth to achieve an absorbance value of 0.05. The biofilm 
assay was then carried out using a 96-well Microplate (Costar, Corning Incorporated, NY, USA). 
The procedure was adapted from Merritt
 
et al., 2006 [29]. The blank was 200 μl of fresh LB/Glu 
Broth. Two controls were used; 200 μl of the diluted overnight culture of P. aeruginosa was 
pipetted in 16 wells each. These were checked after 12 h and after 24 h. To check the effect of 
the GPC on biofilm, 200 μl of the diluted overnight culture was incubated (in 16 wells) for 12 h 
to form biofilm, the GPC was then added aseptically and biofilm levels were checked after 
another 12 h of incubation (24hr in total). Figure 3 offers a schematic diagram of the contents of 
each well.  
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Figure 3: Contents of the 96-well microplate used to analyze the biofilm and biofilm removal. 
The microplate was incubated at 30°C (24 h), after which it was overturned, its contents emptied 
and the wells rinsed out three times with sterilized distilled water. 250μl of 0.1% crystal violet 
stain (Sigma Aldrich, Dublin, Ireland) was pipetted into each of the wells used (residence time, 
5min). The contents were then removed and rinsed out three times with sterilized distilled water. 
276 μl of a 20:80% acetone:ethanol mix (Sigma Aldrich, Dublin, Ireland) was pipetted into the 
used wells and left for a further five minutes to solubilize the attached biofilm. The absorbance 
of the wells was then tested at 595nm on a Microplate Reader (BioTek, Mason Technology, 
Dublin, Ireland) to determine if there was a difference in the absorbance between the contents of 
the wells containing, and those free of, GPC at the different time intervals. Figure 4 shows that 
the absorbance values of the wells containing biofilm after 12hr was 0.571 (SD 0.206) and after 
24 h 0.924 (SD 0.219). The wells containing the biofilm and the GPC (that was added after 12hr 
growth) had an absorbance of 0.302 (SD 0.076).  Therefore a significant statistical difference 
(p<0.001) was observed at 12 h between wells containing biofilm and those containing biofilm 
and GPC (T-test; Microsoft Excel, California, USA). The experiment was repeated with the 
biofilm left to grow for 24 h before the addition of the GPC (Figure 4), which shows that the 
absorbance values of the wells containing the biofilm and the GPC (added after 24 h growth) had 
an absorbance of 2.02 (SD 0.411). 
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Figure 4: Absorbance levels of the growth of biofilm in the well plates containing biofilm alone 
and those containing the biofilm and GPC. 
 
The literature reports a similar study using polymethylmethacrylate (PMMA) cement 
(VersaBond; Smith & Nephew, Memphis, TN, USA), where high absorbance rates, similar to 
those in the wells containing solely biofilm in this study, indicated that PMMA was unable to 
eliminate biofilm [28]. Therefore the reduction in absorbance in the wells that contained the 
novel Zn-Ag-GPC in this study indicates that the cement partially eliminated the biofilm present 
and prevented the formation of any more. Biofilm formation on medical devices has severe 
health consequences as it provides a sanctuary for bacteria, which are tolerant to both host 
defence mechanisms and antibiotic therapies. This study has shown that a novel Zn-Ag-GPC can 
inhibit such biofilm formation and partially reduce the levels of biofilm in vitro indicating that it 
may be possible to produce coatings or cements from this novel Zn-Ag glass that retard or 
partially inhibit biofilm formation from Ps. Aeruginosa. 
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